Eledon Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
50.00 |
0.00 |
0.00 |
5.80 |
39.72 |
| Przychód Δ r/r |
0.00% |
inf% |
-100.00% |
0.00% |
inf% |
584.84% |
| Przychód (min) |
0.00 |
50.00 |
0.00 |
0.00 |
5.80 |
39.72 |
| Przychód (max) |
0.00 |
50.00 |
0.00 |
0.00 |
5.80 |
39.72 |
| EBITDA (średnia) |
0.00 |
30.00 |
0.00 |
0.00 |
3.48 |
23.83 |
| EBIT (średnia) |
0.00 |
30.00 |
0.00 |
0.00 |
3.48 |
23.83 |
| EBIT % |
0.00% |
60.00% |
0.00% |
0.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-19.05 |
-39.53 |
-44.83 |
-49.67 |
-50.24 |
-32.40 |
| Zysk netto % |
-inf% |
-79.06% |
-inf% |
-inf% |
-866.26% |
-81.58% |
| EPS (średnia) |
-0.70 |
-0.81 |
-0.96 |
-0.99 |
-1.03 |
-0.67 |
| Liczba analityków (Przychody) |
0 |
3 |
0 |
0 |
1 |
2 |
| Liczba analityków (EPS) |
4 |
5 |
4 |
4 |
3 |
2 |
| symbol |
ELDN |
ELDN |
ELDN |
ELDN |
ELDN |
ELDN |